We are live on ! Find out more
BIAF icon

bioAffinity Technologies
BIAF

13 hedge funds and large institutions have $484K invested in bioAffinity Technologies in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

110% more capital invested

Capital invested by funds: $231K → $484K (+$254K)

30% more funds holding

Funds holding: 10 → 13 (+3)

0.02% more ownership

Funds ownership: 0.05% → 0.07% (+0.02%)

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$87.5K
2
Renaissance Technologies
Renaissance Technologies
New York
+$65.2K
3
Northern Trust
Northern Trust
Illinois
+$23.7K
4
SBIA
Sheaff Brock Investment Advisors
Indiana
+$17.4K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.24K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$31.8K
2
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$20.9K
3
Bank of America
Bank of America
North Carolina
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$142K +$87.5K +1,677 +251%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$85K +$9.24K +177 +14%
Renaissance Technologies
3
Renaissance Technologies
New York
$76K +$65.2K +1,250 New
CAPTRUST Financial Advisors
4
CAPTRUST Financial Advisors
North Carolina
$56.3K -$20.9K -400 -30%
State Street
5
State Street
Massachusetts
$35.6K – – –
Northern Trust
6
Northern Trust
Illinois
$27.6K +$23.7K +455 New
Creative Planning
7
Creative Planning
Kansas
$24.4K – – –
SBIA
8
Sheaff Brock Investment Advisors
Indiana
$20.2K +$17.4K +333 New
IA
9
IFP Advisors
Florida
$10.1K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$6.76K +$678 +13 +13%
CS
11
Clear Street
New York
$202 +$157 +3 New
Wells Fargo
12
Wells Fargo
California
$91 +$52 +1 +100%
Qube Research & Technologies (QRT)
13
Qube Research & Technologies (QRT)
United Kingdom
$77 – – –
JP Morgan Chase
14
JP Morgan Chase
New York
$26 – – –
Two Sigma Investments
15
Two Sigma Investments
New York
– -$31.8K -721 Closed
Bank of America
16
Bank of America
North Carolina
– -$8 – –

BIAF Hedge Fund Activity: Q1 2024 in Review

13 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q1 2024, worth a combined $484K — up 110% from $231K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIAF positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $87.5K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $31.8K sold.

  • 13 institutional investors held bioAffinity Technologies (BIAF) as of Q1 2024, up from 10 in Q4 2023.
  • Funds reported $484K of bioAffinity Technologies stock for Q1 2024, up 110% quarter-over-quarter.
  • 4 funds opened new bioAffinity Technologies positions in Q1 2024 and 1 closed out, a net change of +3 holders.
  • The largest bioAffinity Technologies buyer in Q1 2024 was Vanguard Group, an estimated $87.5K added.
  • The largest bioAffinity Technologies seller in Q1 2024 was Two Sigma Investments, an estimated $31.8K sold.

Based on aggregated 13F filings for Q1 2024.